Identification of novel SCD1 inhibitor alleviates nonalcoholic fatty liver disease: critical role of liver-adipose axis

Due to the complexity and incomplete understanding of the crosstalk between liver and adipose tissue, especially the processes of hepatic lipogenesis and adipogenic differentiation, there are currently no effective drugs for the treatment of nonalcoholic fatty liver disease (NAFLD). Stearoyl-coenzym...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Wei, Kong, Yulin, Wang, Xia, Wang, Zhe, Tang, Chunlei, Li, Jinyou, Yang, Qin, Chen, Yong Q., Zhu, Shenglong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544195/
https://www.ncbi.nlm.nih.gov/pubmed/37777801
http://dx.doi.org/10.1186/s12964-023-01297-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10544195/
https://www.ncbi.nlm.nih.gov/pubmed/37777801
http://dx.doi.org/10.1186/s12964-023-01297-9

Ejemplares similares